5。
[0356] 10-(5-氯-8-甲氧基喹啉-2-基)癸-1-醇(Hla)及乙酸10-(5-氯-8-甲氧基喹啉-2-基)癸酯(Hlb)
[0357] YD:61%及 10% .Hla:1!! NMR(200MHz,CDCl3)S8.41(d,J = 8.68Hz,lH),7.42(dd,J = 8Hz,J = 2Hz,2H) ,6.91 (d,J = 8Hz,lH) ,4.03(s,3H) ,3.59(t,J = 6Hz,2H) ,3.59(t,J = 4Hz,2H),1 · 73(m,2H),1 · 48(m, 2H),1 · 25(br,12H);HRMS(EI):計算值C20H28CINO2:349 · 1803, 實際值:349.1781 .Hlb:咕 NMR(400MHz,CDC13)S8.41((1,J = 8Hz,lH),7.42(dd,J = 8Hz,J = 4Hz,2H),6.92(d,J = 8Hz,lH),4.06(t,J = 8Hz,2H),4.02(s,3H),3.03(t,J = 8Hz,2H) ,2.02 (s,3H),1.79(m,2H),1.59(m,2H),1.40(m,2H),1.23(br,12H) ;HRMS(FAB,M+H):計算值 C22H3iC1N03392 · 1992,實際值392 · 1983。
[0358] 丨丨-^-氯-^甲氧基喹啉^-基丨^^一―丨-醇(H2a)及乙酸11-(5-氯-8-甲氧基喹啉-2_基)十一酯(H2b)
[0359] YD:60%及 12% .取已:1!! NMR(400MHz,CDCl3)S8.43(d,J = 8.72Hz,lH),7.44(dd,J = 13.5Hz ,J = 5.3Hz,2H),6.94(d ,J = 8.3Hz,lH) ,4.05(s ,3H), 3.62(t ,J = 6.6Hz , 2H) ,3.07 (t,J = 5.2Hz,2H),1.80(m,2H),1.54(m,2H),1.39(m,2H),1.26(br,12H);HRMS(EI):計算值 C2iH3〇C1N〇2363 · 1960,實際值363 · 1941 · H2b: 4 匪R(400MHz,CDC13)S8 · 41 (d,J = 8 · 6Hz, 1H) ,7.42(dd,J = 8.3Hz,J = 3.8Hz,2H) ,6.91(d,J = 8.4Hz,lH) ,4.06(t,J = 7.8Hz,2H), 4.02(s,3H),3.02(t,J=7.8Hz,2H),2.01(s,3H),1.78(m,2H),1.58(m,2H),1.39(m,2H), 1 · 22(br, 12H);HRMS(EI):計算值C23H32CINO3405 · 2065,實際值405 · 2044。
[0360] 12-(5-氯-8-甲氧基喹啉-2-基)十二-1-醇(H3a)及乙酸12-(5-氯-8-甲氧基喹啉-2_基)十二酯(H3b)
[0361] YD:57%及27% .把已:1!! NMR(400MHz,CDCl3)S8.46(d,J = 8.6Hz,lH),7.44(dd,J = 8.3Hz ,J = 6.9Hz,2H),6.94(d ,J = 8.4Hz,lH),4.04(s,3H), 3.59(t,J = 6.6Hz,2H), 3.11 (t, J = 7.8Hz,2H),1.78(m,2H),1.50(m,2H),1.40(m,2H),1.23(br,14H) ;HRMS(EI):計算值 C22H32CINO2377 · 2116,實際值377 · 2106 .H3b:咕匪R(200MHz,CDC13)S8 · 38(d, J = 8 · 7Hz, 1H) ,7.40(d ,J = 8.6Hz,2H),6.88(d ,J = 8.4Hz,lH) ,4.03(t ,J = 7.8Hz , 2H) ,4.01 (s , 3H), 3.02(t J = 7.8Hz,2H),1.99(s,3H),1.76(m,2H),1.59(m,2H),1.20(br,16H);HRMS(FAB,M+ H):計算值C24H35CINO342O · 2305,實際值420 · 2310。
[0362] 13-(5-氯-8-甲氧基喹啉-2-基)十三-1-醇(H4a)及乙酸13-(5-氯-8-甲氧基喹啉-2-基)十三酯(H4b)
[0363] YD:64%及 14% .Ma:1!! NMR(400MHz,CDCl3)S8.46(d,J = 8.6Hz,lH),7.45(dd,J = 8.3Hz ,J = 6.9Hz,2H),6.94(d ,J = 8.4Hz,lH),4.04(s,3H),3.59(t ,J = 6.6Hz,2H),3.11(t, J = 7.8Hz,2H) ,1.78(m,2H) ,1.50(m,2H),1.40(m,2H) ,1.23(br,16H) ;HRMS(EI):計算值 C23H34C1N02391 · 2273 ,實際值391 · 2249 · H4b: 4 匪R(400MHz , CDC13)δ8 · 38(d, J = 8 · 6Hz, 1H) ,7.40(dd,J = 8.5Hz,J = 5.8Hz,2H) ,6.89(d,J = 8.4Hz,lH) ,4.01(t,J = 9.6Hz,2H), 4.00(s,3H),3.00(t,J=7.9Hz,2H),1.99(s,3H),1.75(m,2H),1.58(m,2H),1.38(m,2H), 1 · 22(br, 16H);HRMS(FAB,M+H):計算值C25H37CINO3434· 2462,實際值434· 2459。
[0364] 實施例7-制備(8-羥基喹啉-4-基)或(8-烷氧基喹啉-4-基)烷基醇
[0365] 1234 試劑與條件:(a)甲基乙烯基酮,HC1,回流.(b)Mel,Κ2ω3,丙酮,rt,8h;EtI或2-溴 丙烷或亞甲基環(huán)丙基溴,1( 20)3,01^,60°(3,((3)1)1^]\?)3,1'冊,0°(3,111.;2)8^01 2)11-10!1,^ (d) BnBr,Κ0Η,EtOH,回流·( e) H2,Pd/C,MeOH,rt,24h。 2 方法:由2-胺基苯酚與甲基乙烯基酮反應(yīng)通過閉環(huán)反應(yīng)合成中間體INT 1。將INT 1與各種鹵烷反應(yīng)以提供8-烷氧基-4-甲基喹啉衍生物作為中間體。將對應(yīng)的BHCftOnOH 與中間體反應(yīng)以合成一系列化合物J及I。利用氫化反應(yīng)(該方法于實施例1中說明)移除保 護基J,以獲得化合物K。 3 ^-(^甲氧基喹啉^-基)^-一-1-醇(II) 4 YD:34% .? NMR(400MHz,CDCl3)S8.80(dd,J = 4.4,0.6Hz,lH),7.59(dd,J = 8.4, 0.8Hz,lH),7.44-7.49(m,lH),7.03(d,J = 7.6Hz,lH),4.08(s,3H),3.63(t,J = 6.8Hz,2H), 3.03(t,J = 7.6Hz,2H) ,1.74(quin,J = 7.6Hz,2H) ,1.55(quin,J = 7.2Hz,2H), 1.23-1.45 (br,15H);MS.m/z329.9,[M+H]+〇
[0370] ^-(^乙氧基喹啉^-基)^-一-1-醇(12)
[0371] YD:42% ·Η 匪R(400MHz,d4-Me0D)S8.66((1, J = 8.4Hz,lH),7.64((1, J = 8.4Hz, 1H) ,7.51(t ,J = 8.0Hz,lH) ,7.37(d ,J = 8.4Hz,lH) ,7.15(d ,J = 7.6Hz,lH) ,4.27(q ,J = 6.8Hz,2H) ,3.52(t,J = 6.8Hz,2H) ,3.08(d,J = 7.6Hz,2H) ,1,75(quin,J = 7.6Hz,2H), 1·50-1·57(m,5H),1·21-1.49(br,15H);MS.m/z 366.2,[M+Na]+。
[0372] n-(8-異丙氧基喹啉-4-基^一―丨-醇(I3)
[0373] YD:48% MMR(400MHz,d4-MeOD)S8.65((1, J = 8.4Hz,lH),7.63((1, J = 7.6Hz, 1H) ,7.51(d ,J = 8.0Hz,lH) ,7.35(d ,J = 4.4Hz , 1H), 7.17(d ,J = 8.0Hz , 1H) ,4.84(br, 1H), 3.52(t ,J = 6.4Hz,2H), 3.07(d,J = 7.6Hz, 2H) ,1.74(br,2H), 1.43-1.50(br,9H), 1.29-1.34(br,14H);MS.m/z380.3,[M+Na]+。
[0374] n-(8-(環(huán)丙基甲氧基)喹啉-4-基^一-1-醇(14)
[0375] YD:53% MMR(400MHz,d4-MeOD)S8.66((1, J = 8.4Hz,lH),7.63((1, J = 8.4Hz, 1H) ,7.49(t ,J = 8.4Hz,lH) ,7.36(d ,J = 4.8Hz,lH) ,7.13(d ,J = 7.6Hz,lH) ,4.03(d ,J = 6.8Hz,lH) ,3.52( t,J = 6.8Hz,2H), 3.06(d,J = 7.6Hz,2H) ,1.69-1.75(m,2H), 1.28-1.52 (br,18H),0.65-0.68(m,2H),0.42-0.43(m,2H);MS.m/z 392.2[M+Na]+。
[0376] n-(8-(苯甲氧基)喹啉-4-基^一-1-醇(J1)
[0377] YD:46% MMR(400MHz,d4-Me0D)S8.66(d,J = 8.4Hz,lH),7.64(d,J = 8.4Hz, 1H),7.52(d,J = 7.2Hz,2H),7.45(t,J = 8.0Hz,lH) ,7.30-7.38(m,3H) ,7.26-7.28(m,lH), 7.17(d ,J = 7.6Hz,lH),5.37(s,2H),3.52(t ,J = 6.4Hz,2H),3.06(t ,J = 8Hz,2H),1.73(q ,J =7.6Hz,2H),1.50(t,J = 7.2Hz,2H),l .28-1.48(m,15H);MS.m/z 428.3,[M+Na] +。
[0378] 12-(8-(苯甲氧基)喹啉-4-基)十二-1-醇(J2)
[0379] YD:46% MMR(400MHz,d4-MeOD)S8.67((1, J = 4.4Hz,lH),7.65((1, J = 8.4Hz, 1H) ,7.52(d,J = 7.2Hz,2H),7.45(t,J = 8.0Hz,lH),7.30-7.39(m,3H),7.27-7.30(m,lH), 7.18(d,J = 8.0Hz,lH) ,5.38(s,2H) ,3.52(t,J = 6.4Hz,2H) ,3.08(t,J = 7.6Hz,2H) ,1.74 (q,J = 7.6Hz,2H),1.49(t,J = 7.2Hz,2H),1.23-1.45(m,17H);MS.m/z 442.3, [M+Na] +。
[0380] 4-(11-輕^-一基)喹啉-8-醇(K1)
[0381] YD:84% 匪R(400MHz,d4-Me0D)S8.63((1, J = 4.4Hz,lH),7.51((1, J = 8.4Hz, 1H) ,7.40( t,J = 8.0Hz,lH) ,7.28(d,J = 4.0Hz,lH) ,7.06(d,J = 7.6Hz,lH), 3.51( t,J = 6.8Hz,2H) ,3.02(t,J = 8.0Hz,2H) ,1,71(t,J = 7.6Hz,2H) ,1,50(quin,J = 6.8Hz,2H), 1.12-1.31(br,15H);MS.m/z 316.2,[M+H]+〇
[0382] 4-( 12-輕十二基)喹啉-8-醇(K2)
[0383] YD:86% NMR(400MHz,CDCl3)S8.52(d,J = 4.4Hz,lH),7.36(dd,J = 8.4,0.8Hz, lH),7.31(d ,J = 7.6Hz,lH),7.13(d ,J = 4.4Hz,lH),6.99(dd ,J = 7.6,1.2Hz,lH),3.43(t ,J = 6.8Hz,2H) ,2.89(t,J = 7.6Hz,2H) ,1.61 (quin, J = 7.6Hz,2H) ,1.40(quin,J = 6.8Hz, 2H),1.12-1.31(br,17H);MS.m/z 352.2,[M+Na]+。
[0384] 實施例8-制備(8-三氟甲氧基喹啉-2-基)烷基醇
[0385:
[0386] 方法:將2-三氟甲氧基苯胺與巴豆醛反應(yīng)以通過閉環(huán)反應(yīng)合成中間體。將中間體 與對應(yīng)的Br(CH2) n-iOH(如上所述)反應(yīng)以合成一系列化合物L。
[0387] 9-( 8-(三氟甲氧基)喹啉-2-基)壬-丨-醇(L1)
[0388] YD:41% NMR(400MHz,CDCl3)S8.06(dd,J = 8.4,1.2Hz,1H),7.70((1, J = 8.4Hz, lH),7.56(d ,J = 7.6Hz,lH),7.43(d ,J = 8.0Hz,lH),7.34(dd ,J = 8.4,1.2Hz,lH), 3.61 (tj = 6.4Hz,2H), 3.01( t,J = 6.4Hz,2H) ,1.81-1.85(br,2H) ,1.53-1.56(br,2H), 1.21-1.35 (m,15H);MS.m/z355.9,[M+H]+〇
[0389] !丨-(8-(三氟甲氧基)喹啉-2-基)^^一-1 -醇(L2)
[0390] YD:41% MMR(400MHz,d4-Me0D)S8.26(t,J = 8.0Hz,lH),7.86(d,J = 7.6Hz, 1H), 7.64( t,J = 7.2Hz,lH) ,7.47-7.56(m, 2H), 3.51 (t ,J = 6.8Hz , 2H), 2.99(t ,J = 6.4Hz , 2H), 1.79(quin, J = 6.8Hz,2H),l. 50(quin, J = 6.8Hz,2H), 1.21-1.35 (m,15H);MS.m/z 406.2, [M+Na] +。
[0391] 14-( 8-(三氟甲氧基)喹啉-2-基)十四-卜醇(L3)
[0392] YD:37% MMR(400MHz,d4-MeOD)S8.27((1, J = 8.4Hz,lH) ,7.87((1, J = 8.0Hz, 1H), 7.65( t,J = 7.2Hz,lH) ,7.49-7.56(m, 2H), 3.52( t ,J = 6.8Hz , 2H), 3.01 (t ,J = 7.6Hz , 2H), 1.82(quin, J = 7.2Hz,2H), 1.51 (quin, J = 6.8Hz,2H), 1.27-1.37 (m,21H);MS.m/z 448.2, [M+Na] +。
[0393] ! 5-( 8-(三氟甲氧基)喹啉-2-基)十五-丨-醇(L4)
[0394] YD:32%.1HMMR(400MHz,d4-Me0D+CDCl3)S8.21(d,J = 8.4Hz,lH),7.81(d,J = 8.0Hz,lH),7.61(d ,J = 7.6Hz,lH),7.51(d ,J = 8.0Hz,lH),7.46(t ,J = 8.4Hz,lH),3.52(t, J = 6.8Hz,2H) ,2.99(t,J = 7.6Hz,2H) ,1.80(quin,J = 7.6Hz,2H) ,1.50(quin,J = 7.2Hz, 2H),1.15-1.41(br,23H);MS.m/z 462.2,[M+Na]+。
[0395] 實例9-制備2-N-取代-8-羥基/烷氧基喹啉
[0397] 試劑與條件:(a)Se02,二惡烷,50至80°C; (b)N_甲基丙炔胺或2_(哌嗪-1-基)乙醇 或順2(〇12)11-10!1,恥8!1((^。)3,1,2-二氯乙烷,竹。
[0398] 方法:在50°C下逐滴將8-羥基-2-甲基喹啉(6 · 0g,37 · 7mmol)的二惡烷(15ml)溶液 添加至Se02 (6.3g,56.8mmol)的二惡烷(80ml)攪拌溶液,并將混合物加熱至80°C再20小時。 過濾所形成的混合物。濃縮濾液,并將殘余物利用管柱層析法以Hex/EA= (15:1至10:1)進 行純化以獲得8-羥基喹啉-2-羧醛(2.45g,38%)衍生物作為中間體。以胺基醇、胺基炔或其 他雜環(huán),利用還原胺化反應(yīng)將中間體轉(zhuǎn)化為N-取代化合物,以提供一系列化合物。將8-烷氧 基-2-甲基喹啉氧化以提供8-烷氧基喹啉-2-羧醛衍生物,之后并以相同方法獲得化合物Μ 至0〇
[0399] 2-((4-(2-輕乙基)哌嗪-卜基)甲基)喹啉-8-醇(Ml)
[0400] YD:76% .? NMR(400MHz,CDCl3)S8.02((1, J = 8.4Hz,lH),7.43((1, J = 8.4Hz,lH), 7.34(t,J = 8.0Hz,lH) ,7.22(d,J = 7.6Hz,lH) ,7.10(d,J = 6.8Hz,lH) ,3.73(s,2H) ,3.61 (^ = 6.8抱,2!〇,2.51(扒了 = 5.6抱,10!〇;!11?^化51):計算值[]\?^] + :310.1526,實際值: 310.1527。
[0401] 2-(4-((5-氯-8-甲氧基喹啉-2-基)甲基)哌嗪-丨-基)乙醇( M2)
[0402] YD:76% .? NMR(400MHz,CDCl3)S8.23((1, J = 8.8Hz,lH),7.59((1, J = 8.8Hz,lH), 7.21(d,J = 8.4Hz, 1H) ,6.68(d,J = 8.8Hz,lH) ,3.81(s,3H) ,3.72(s,2H) ,3.44(t,J = 4.8Hz,2H),2.35-2.38(m,10H);MS,m/z336.1,[M+H]+〇
[0403] 2-(4-( (5-氯-8-乙氧基喹啉-2-基)甲基)哌嗪-1-基)乙醇(M3)
[0404] YD:53% .? NMR(400MHz,CDCl3)S8.36((1, J = 8.8Hz,lH) ,7.68((1, J = 8.4Hz,lH), 7.34(d ,J = 8.4Hz,lH) ,6.83(d ,J = 8.4Hz , 1H) ,4.18(q ,J = 6.8Hz , 3H), 3.84(s, 2H), 3.54 (t ,J = 5.2Hz,2H),2.45-2.50(br,10H),1.49(t ,J = 6.8Hz,3H);MS.m/z 350.1, [M+H] + 〇
[0405] 2-(4-( (5-氯-8-異丙氧基喹啉-2-基)甲基)哌嗪-1-基)乙醇(M4)
[0406] YD:61% 匪R(400MHz,d4-Me0D)S8.52(d,J = 8.8Hz,lH),7.81(d,J = 8.8Hz, 1H) ,7.53(d ,J = 8.4Hz,lH) ,7.14(d ,J = 8.4Hz , 1H) ,4.87(m, 1H), 3.89(s , 2H), 3.67(t ,J = 6.0Hz,2H),2.54-2.62(br,10H),1.45(t,J=6.0Hz,6H);MS.m/z 364.1,[M+H]+〇
[0407] 2-(4-((5-氯-8-(環(huán)丙基甲氧基)喹啉-2-基)甲基)哌嗪-1-基)乙烷(M5)
[0408] YD:76% 匪R(400MHz,d4-Me0D)S8.40(d,J = 8.4Hz,lH),7.71(d,J = 8.8Hz, 1H),7.42(d,J = 8.4Hz,lH),6.99(d,J = 8.4Hz,lH),3.97(d,J = 6.8Hz,2H),3.84(s,2H), 3.65(tJ = 6.0Hz,2H),3.44(t,J = 4.8Hz,2H),2.56(br,8H),2.51(tJ = 4.8Hz,2H),1.37-1.43(m,lH),0.62-0.66(m,2H),0.37-0.40(m,2H);MS.m/z 376.2,[M+H]+〇
[0409] 2-(4-( (5,7-二氯-8-甲氧基喹啉-2-基)甲基)哌嗪-1-基)乙醇(M6)
[0410] YD:39% 匪R(400MHz,d4-Me0D)S8.53((1, J = 8.8Hz,lH) ,7.80((1, J = 8.8Hz, lH),7.70(s,lH),4.11(s,3H),3.89(s,2H),3.67(t,J=6.0Hz,2H),2.63(br,8H),2.55(t,J =6.0Hz,2H),1.93(s,lH);MS.m/z370.1,[M+H]+〇
[0411] 2-(4-((5,7-二氯-8-(環(huán)丙基甲氧基)喹啉-2-基)甲基)哌嗪-卜基)乙醇(M7)
[0412] YD:82% .? NMR(400MHz,CDCl3)S8.43((1, J = 8.8Hz,lH) ,7.71((1, J = 8.8Hz,lH), 7.58(s,lH),4.22(d ,J = 7.2Hz,2H),3.88(s,2H)3.61(t ,J = 6.4Hz,2H),2.56(t ,J = 5.2Hz, 10H),1.41-1.44(m,lH),0.57-0.62(m,2H),0·33-0.37(m,2H);MS.m/z 410.1,[M+Na]+。
[0413] 2-((甲基(丙-2-炔基)胺基)甲基)喹啉-8-醇(N1)
[0414] YD:49% .? NMR(400MHz,CDCl3)S8.08((1, J = 8.4Hz,lH),7.55((1, J = 8.4Hz,lH), 7.40(t,J = 8.0Hz,lH) ,7.28(d,J = 8.0Hz,lH) ,7.15(d,J = 7.6Hz,lH) ,3.90(s,2H) ,3.41 (d ,J = 2.0Hz,2H),2.39(s,3H),2.31(d ,J = 2.0Hz,lH);MS.m/z 249.1, [M+H] + 〇
[0415] 5-氯-2-((甲基(丙-2-炔基)胺基)甲基)喹啉-8-醇(N2)
[0416] YD:38% .? NMR(400MHz,CDCl3)S8.47((1, J = 8.4Hz,lH) ,7.71((1, J = 8.8Hz,lH), 7.47(d,J = 8.0Hz,lH) ,7.08(d,J = 8.4Hz,lH) ,3.93(s,2H) ,3.42(d,J = 2.0Hz,2H) ,2.40 (s,3H),2.31(t ,J = 2.0Hz,lH);MS.m/z 261.0, [M+H] + 〇
[0417] N-((5-氯-8-甲氧基喹啉-2-基)甲基)-N_甲基丙-2-炔-1-胺(N3)
[0418] YD:52% .? NMR(400MHz,CDCl3)S8.48((1, J = 8.8Hz,lH) ,7.80((1, J = 8.8Hz,lH), 7.46(d,J = 8.4Hz, 1H) ,6.93 (d,J = 8.4Hz,lH) ,4.05( s,3H) ,4.00( s,2H) ,3.42(d,J = 2.0Hz,2H),2.37(s,3H),2.27(t,J = 2.0Hz,lH),MS.m/z 297.0,[M+Na] +。
[0419] N-((5_氯-8-乙氧基喹啉-2-基)甲基)-N_甲基丙-2-炔-1-胺(N4)
[0420] YD:64% .? NMR(400MHz,CDCl3)S8.48((1, J = 8.8Hz,lH),7.79((1, J = 8.8Hz,lH), 7.46(d ,J = 8.8Hz,lH) ,6.96(d ,J = 8.4Hz , 1H) ,4.32( t ,J = 6.8Hz , 2H) ,4.01(s,2H) ,3.45 (d,J = 2.0Hz,2H) ,2.41(s,3H) ,2.28(t,J = 2.0Hz, 1H) ,1.59(t,J = 6.8Hz,3H) ;MS.m/z 289.1,[M+H]+〇
[0421] N-((5-氯-8-異丙氧基喹啉-2-基)甲基)-N-甲基丙-2-炔-1-胺(N5)
[0422] YD:76% .? NMR(400MHz,CDCl3)S8.47((1, J = 8.8Hz,lH) ,7.73((1, J = 8.8Hz,lH), 7.46(d,J = 8.0Hz, 1H) ,7.03 (d,J = 8.4Hz,lH) ,4.80 (m,lH) ,3.99( s,2H) ,3.44(d,J = 2.4Hz,2H),2.41(s,3H),2.28(t,J = 2.4Hz,lH) ,1.48(d,J = 6.4Hz,6H);MS.m/z 303.1,[M+ H] +。
[0423] N-((5-氯-8-(環(huán)丙基甲氧基)喹啉-2-基)甲基)- N-甲基丙-2-炔-!-胺(N6)
[0424] YD:58% .? NMR(400MHz,CDCl3)S8.48((1, J = 8.4Hz,lH) ,7.77((1, J = 8.8Hz,lH), 7.45(d ,J = 8.4Hz,lH) ,6.98(d ,J = 8.4Hz , 1H) ,4.09(d ,J = 7.2Hz , 2H) ,4.01(s,2H) ,3.45 (d, J = 2.0Hz,2H),2.41(s,3H) ,2 · 28(t,J = 2 ·0Ηζ,1H) ,1.42~1 ·50(ι?,1H),0 ·65-0·70(ι?, 2H),0.42-0.45(m,2H);MS.m/z 337.1,[M+Na]+。
[0425] N_( (5,7-二氯-8-甲氧基喹啉-2-基)甲基)-N_甲基丙-2-炔-1-胺(N7)
[0426] YD:58% .? NMR(400MHz,CDCl3)S8.47((1, J = 8.8Hz,lH),7.74((1, J = 8.8Hz,lH), 7.60(s,lH) ,4.20(s,3H) ,3.99( s,2H) ,3.43(d,J = 2.0Hz, 2H) ,2.41 (s,3H) ,2.29( t,J = 2.0Hz,lH);MS.m/z 309.0,[M+H]+〇
[0427] N-((5,7-二氯-8-(環(huán)丙基甲氧基)喹啉- 2-基)甲基)-N-甲基丙-2-炔-!-胺(N8)
[0428] YD:76% .? NMR(400MHz,CDCl3)S8.45((1, J = 8.8Hz,lH),7.71((1, J = 8.8Hz,lH), 7.59(s,lH),4.25(d,J = 7.6Hz,2H),3.95(s,2H),3.40(d,J = 2.0Hz,2H),2.40(s,3H) ,2.28 (t,J = 2.0Hz,lH) ,1.41-1.45(m,lH) ,0.57-0.62(m,2H) ,0.36(dd, J= 10.0,4.8Hz , 2H); MS.m/z 371.0,[M+Na]+。
[0429] 8-((5-氯-8-甲氧基喹啉- 2-基)甲基胺基)辛-丨-醇(01)
[0430] YD:44% 匪R(400MHz,d4-Me0D)S8.55((1, J = 8.8Hz,lH),7.69((1, J = 8.8Hz, 1H),7.58(d,J = 8.4Hz,lH),7.16(d,J = 8.4Hz,lH),4.07(s,5H),3.50(t,J = 6.8Hz,2H), 2.63(t ,J = 7.2Hz,2H) ,1.56(quin,J = 7.2Hz,2H) ,1.50(quin ,J = 6.8Hz,2H), 1.29-1.32 (br,10H);MS.m/z351.2,[M+H]+〇
[0431 ] 8-( (5-氯-8-乙氧基喹啉-2-基)甲基胺基)辛-1-醇(02)
[0432] YD:41%.1HMMR(400MHz,d4-Me0D)S8.51(d,J = 8.8Hz,lH),7.66(d,J = 8.4Hz, 1H),7.53(d,J = 8.4Hz,lH),7.12(d,J = 8.4Hz,lH),4.29(q,J = 6.8Hz,2H),4.07(s,2H), 3.51(t ,J = 6.8Hz, 2H), 2.64(t,J = 7